Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile : Anti-Cancer Drugs

Journal Logo

REVIEW ARTICLES

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population

review of patient profile

Vázquez, Sergioa; Lázaro, Martínb; Fírvida, José Luisd; Santomé, Lucíac; Afonso, Javiere; Amenedo, Margaritaf; Casal, Joaquínb On Behalf of the Galician Lung Cancer Group (GGCP)

Author Information
Anti-Cancer Drugs 25(4):p 368-374, April 2014. | DOI: 10.1097/CAD.0000000000000066

Abstract

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

You can read the full text of this article if you:

Access through Ovid